Overall rank by patents
#3,455
Across all tracked assignees
USPTO PatentsView assignee record - 107 granted patents across 30 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION).
The verdict
Nxgen holds 107 US patents across 30 technology areas, rank #3,455 of 50,000 tracked assignees.
Nxgen Partners IP, Llc has been granted 107 US utility patents between 2016 and 2025, placing Nxgen Partners IP, Llc at rank #3,455 across all assignees tracked by PlainPatent. This portfolio spans 30 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.0 claims per patent with primary concentration in H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION). As a US Corporation, Nxgen Partners IP, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Nxgen sits between Elbit Systems Ltd. (107 patents, rank #3,451) and Sacmi Cooperativa Meccanici Imola Societa' Cooperativa (107 patents, rank #3,459) - the closest US assignees by grant volume. The composite Innovation Score of 51.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 51 grants, compared with 56 in the 2015–2019 window, a -9% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Nxgen Partners IP, Llc's 22.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 30 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Nxgen Partners IP, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Elbit Systems Ltd.
107 patents
GALDERMA RESEARCH & DEVELOPMENT
107 patents
JILIN UNIVERSITY
107 patents
MITSUI HIGH-TEC, INC.
107 patents
Ohio University
107 patents
Persimmon Technologies Corporation
107 patents
Reckitt Benckiser Finish B.V.
107 patents
SACMI COOPERATIVA MECCANICI IMOLA SOCIETA' COOPERATIVA
107 patents
NxGen Partners IP, LLC
107 patents
What this shows Nxgen holds 107 patents at rank #3,455, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,455 in granted patent volume.
Other assignees with the most granted patents in Nxgen's primary technology class.
Nxgen's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
52 Top 11% higher than 89% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 6 | 5.6% |
| 2017 | 11 | 10.3% |
| 2018 | 18 | 16.8% |
| 2019 | 21 | 19.6% |
| 2020 | 13 | 12.1% |
| 2021 | 14 | 13.1% |
| 2022 | 10 | 9.3% |
| 2023 | 7 | 6.5% |
| 2024 | 4 | 3.7% |
| 2025 | 3 | 2.8% |
Top 15 of 30 technology areas
Overall rank by patents
#3,455
Across all tracked assignees
51.6 out of 100
How to use this portfolio
Nxgen's 107 grants land it in the top 11% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.